noScript

Is COVID Really Over? Experts Disagree

Is COVID really over? On September 21, 2022, U.S. President Joe Biden declared that “the pandemic was over,” sparking wide-ranging debates in the scientific community. This declaration came after the World Health Organization (WHO) had declared, on March 11, 2020, that the COVID-19 outbreak, which originated in China, had become a pandemic. The disease spread rapidly worldwide, resulting in more than 600 million confirmed cases and at least 6 million deaths as of October 2022.

Is COVID really over? Experts weigh in

President Biden’s statement was disputed by several public health experts, who argued that, considering the global nature of a pandemic, it is inappropriate for one country to simply declare that it has ended, especially when that country, i.e., U.S., is seeing more than 71,000 new cases and 400 deaths due to COVID-19 every day. Globally, nearly 500,000 cases and 2,000 deaths are being reported on a daily basis.3 Indeed, the WHO Director-General has stated that the pandemic is not over yet, although the end is firmly in sight and the worst seems to be behind us.4

However, some experts have contrasting views and believe that while we have moved past the pandemic phase, we have now entered an endemic phase of COVID-19, as reflected by the return to “normalcy” in multiple walks of life. They believe that COVID-19 will never disappear completely and that we would need to adapt to it even though this doesn’t mean that we discontinue any necessary precautions or countermeasures.3

Is COVID really over? Public perception

Experts believe that President Biden’s statements reflect the sentiments of the general public, which is now experiencing a return to pre-pandemic life following vaccination.3 However, they warn that this perception could endanger the vulnerable sections of the society, such as immunocompromised adults and those with contraindicated vaccines. Moreover, the threat of “long COVID,” long-term symptoms following COVID-19 infections, cannot be ignored.5

Is COVID really over? Global perspectives

While COVID-19 seems to be slowing down in most parts of the world, it remains dangerous, especially in low- and middle-income countries. Indeed, vaccination rates still remain low, with around 30% of the world’s population not having received even a single vaccine dose.6 The primary factors preventing the WHO from declaring the pandemic as “over” are the ongoing global death toll and the possibility of continued widespread transmission leading to the development of a dangerous new variant.7

Indeed, the current signs point towards such a trend. A new wave of COVID-19 seems to have started in Europe, the U.K., France, and Italy. In the week of October 5, 2022, the EU witnessed an 8% increase in COVID-19 cases, despite a decrease in the rate of testing.8 Some experts believe that a similar increasing trend could also occur in the U.S., given the parallels between case characteristics in the U.S. and Europe and some modeling studies.9 Meanwhile, a new sublineage of the Omicron variant, called the BF.7 variant and believed to be more infectious, has been detected in China, Belgium, Germany, France, Denmark, England, and India. This has sparked concerns of rapid COVID-19 spread in these countries.10,11

Is COVID really over? Conclusion

Overall, given the rates of disease spread and deaths — both in the U.S. and the rest of the world — it appears that the COVID-19 pandemic is not over. Until everyone is protected, we all remain vulnerable to new variants and seasonal changes in COVID-19 transmission. Although restrictions have been lifted in several parts of the world, experts believe that governments must remain vigilant and take adequate public health protection measures. Clinicians must advise patients to continue taking the necessary precautions, especially if the patients are older, have comorbidities, or are immunocompromised. Meanwhile, efforts should continue being focused on improving vaccination rates and identifying strategies to control transmission and treat COVID-19 effectively.

References

  1. Ohannessian R, Duong T, Odone A. Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action. JMIR Public Health Surveill 2020;6(2):e18810.
  2. WHO Coronavirus (COVID-19) Dashboard. Accessed from: https://covid19.who.int/
  3. Is the Pandemic Over? If Only It Were That Simple. Accessed from: https://www.medscape.com/viewarticle/981236
  4. WHO Director-General’s opening remarks at the media briefing– 14 September 2022. Accessed from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing–14-september-2022
  5. The pandemic is not over: We ignore it at our own risk. Accessed from: https://thehill.com/opinion/healthcare/3692549-the-pandemic-hasnt-ended-the-us-is-ignoring-the-rest-of-the-world/
  6. Mathieu E, Ritchie H, Ortiz-Ospina E, et al. A global database of COVID-19 vaccinations. Nat Hum Behav 2021. Accessed from https://ourworldindata.org/covid-vaccinations
  7. The latest on the coronavirus. Accessed from: https://www.hsph.harvard.edu/news/hsph-in-the-news/the-latest-on-the-coronavirus/
  8. COVID wave looms in Europe as booster campaign makes slow start. Accessed from: https://www.reuters.com/world/europe/covid-wave-looms-europe-booster-campaign-makes-slow-start-2022-10-06/
  9. Early signs a new U.S. COVID surge could be on its way. Accessed from: https://www.npr.org/sections/health-shots/2022/10/07/1127017062/early-signs-a-new-u-s-covid-surge-could-be-on-its-way
  10. China Detects New Variant of COVID-19: How Dangerous Are BF.7 And BA.5.1.7 Variants of Omicron? Accessed from: https://www.thehealthsite.com/news/china-detects-new-variant-of-covid-19-how-dangerous-are-bf-7-and-ba-5-1-7-variants-of-omicron-915267/
  11. India Detects First Case of ‘Highly Infectious’ Omicron Sub-Variant BF.7 That Was Behind China’s Recent COVID-19 Surge. Accessed from: https://weather.com/en-IN/india/coronavirus/news/2022-10-17-india-detects-first-case-of-highly-infectious-omicron-subvariant

About Docquity

If you need more confidence and insights to boost careers in healthcare, expanding the network to other healthcare professionals to practice peer-to-peer learning might be the answer. One way to do it is by joining a social platform for healthcare professionals, such as Docquity

Docquity is an AI-based state-of-the-art private & secure continual learning network of verified doctors, bringing you real-time knowledge from thousands of doctors worldwide. Today, Docquity has over 400,000 doctors spread across six countries in Asia. Meet experts and trusted peers across Asia where you can safely discuss clinical cases, get up-to-date insights from webinars and research journals, and earn CME/CPD credits through certified courses from Docquity Academy. All with the ease of a mobile app available on Android & iOS platforms!

Share it with
Email
Facebook
LinkedIn
Twitter
WhatsApp

Similar Articles

Data Privacy Notice

This Privacy Notice shall be read in conjunction with the Privacy Policy to the extent this Notice does not mention or specify the particulars that should have been mentioned or specified relating to the Notice in pursuance of the provisions of the Data Protection Laws as applicable.

On having accessed or visited this Platform you the Noticee hereby voluntarily consent to and take notice of the fact that the personal data, by which or in relation whereto you the concerned Noticee is identifiable, shall be retained, stored, used, and may be processed by the Company for the purpose and in the manner, though legal, found suitable to it for commercial and/or some other reasons. The detailed specificity whereof may be found in the Privacy Policy. The consent provided herein may be withdrawn anytime by you, the Noticee, at its own volition by removing your profile or by writing to us at support@docquity.com.

As a Noticee, you shall have the right to grievance redressal, in relation to your consent or our use of your personal data, which you may address by writing to us at dpo@docquity.com. Should you, the Noticee, thereafter remain unsatisfied or dissatisfied with the resolution provided by us, you, the Noticee, may approach the concerned regulatory authority for the redressal of your grievance.

Thanks for exploring our medical content.

Create your free account or log in to continue reading.

Data Privacy Notice

By using this platform, you consent to our use of your personal data as detailed in our Privacy Policy, and acknowledge that we use cookies to improve your browsing experience